BioSyent
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BioSyent's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13% to $31,590,302. The net income raised on $6,460,127 and profit margin reached 20%. Total operating expenses were $18,126,803.
Profit Margin
| 2014 | 12.21M | 3.15M | 25.83% |
|---|---|---|---|
| 2015 | 15.38M | 3.76M | 24.47% |
| 2016 | 17.92M | 4.30M | 24.05% |
| 2017 | 20.76M | 5.20M | 25.08% |
| 2018 | 21.52M | 5.70M | 26.5% |
| 2019 | 21.42M | 4.36M | 20.39% |
| 2020 | 22.33M | 3.79M | 16.99% |
| 2021 | 28.61M | 6.28M | 21.95% |
| 2022 | 27.92M | 5.45M | 19.55% |
| 2023 | 31.59M | 6.46M | 20.45% |
RX.V Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 31.59M | 27.92M | 28.61M | 22.33M | 21.42M | 21.52M | 20.76M | 17.92M | 15.38M | 12.21M |
Cost of revenue | 5.99M | 5.06M | 5.98M | 4.90M | 4.77M | 4.95M | 4.78M | 3.79M | 3.27M | 2.68M |
Gross profit | 25.59M | 22.85M | 22.63M | 17.42M | 16.64M | 16.57M | 15.97M | 14.12M | 12.10M | 9.53M |
Operating exp. | ||||||||||
Research and development | 94.98K | 218.49K | 276.54K | 241.55K | 90.11K | 107.45K | 79.87K | 63.84K | 26.37K | 59.95K |
Selling and marketing | 7.56M | 6.42M | 9.07M | 7.42M | 5.75M | 5.26M | 5.30M | 4.82M | 4.02M | 2.99M |
Total operating expenses | 18.12M | 15.95M | 14.39M | 12.29M | 11.25M | 9.77M | 9.59M | 8.37M | 7.05M | 5.27M |
Operating income | 7.47M | 6.98M | 8.18M | 5.03M | 5.38M | 6.79M | 6.85M | 5.75M | 5.05M | 4.25M |
Other income (expenses), net | 1.06M | 448.65K | 195.22K | 206.95K | 482.39K | 426.14K | 412.18K | -14.16K | 108.61K | 72.35K |
Income before tax | 8.53M | 7.43M | 8.37M | 5.23M | 5.87M | 7.54M | 6.85M | 5.86M | 5.16M | 4.32M |
Income tax expense | 2.07M | 1.97M | 2.09M | 1.44M | 1.50M | 1.84M | 1.64M | 1.56M | 1.40M | 1.17M |
Net income | 6.46M | 5.45M | 6.28M | 3.79M | 4.36M | 5.70M | 5.20M | 4.30M | 3.76M | 3.15M |
Earnings per share | ||||||||||
Basic EPS | 0.54 | 0.44 | 0.5 | 0.29 | 0.31 | 0.39 | 0.36 | 0.3 | 0.27 | 0.23 |
Diluted EPS | 0.53 | 0.44 | 0.49 | 0.29 | 0.31 | 0.39 | 0.36 | 0.3 | 0.26 | 0.22 |